ROCA, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 5.420
AS - Asia 2.419
EU - Europa 1.676
SA - Sud America 493
AF - Africa 45
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.064
Nazione #
US - Stati Uniti d'America 5.344
SG - Singapore 849
CN - Cina 825
BR - Brasile 407
UA - Ucraina 378
DE - Germania 338
HK - Hong Kong 283
IT - Italia 192
VN - Vietnam 191
GB - Regno Unito 139
RU - Federazione Russa 128
FI - Finlandia 106
FR - Francia 106
TR - Turchia 86
IE - Irlanda 79
PL - Polonia 66
CA - Canada 46
IN - India 44
AR - Argentina 37
CZ - Repubblica Ceca 36
BD - Bangladesh 33
IQ - Iraq 22
BE - Belgio 20
SE - Svezia 19
JP - Giappone 18
MX - Messico 17
NL - Olanda 17
ES - Italia 14
EC - Ecuador 13
CO - Colombia 12
SA - Arabia Saudita 11
ZA - Sudafrica 11
ID - Indonesia 10
AT - Austria 9
VE - Venezuela 9
MA - Marocco 8
DZ - Algeria 7
UZ - Uzbekistan 7
AU - Australia 6
PY - Paraguay 6
IR - Iran 5
AZ - Azerbaigian 4
CL - Cile 4
EG - Egitto 4
EU - Europa 4
JM - Giamaica 4
LT - Lituania 4
BG - Bulgaria 3
CH - Svizzera 3
HN - Honduras 3
NP - Nepal 3
PK - Pakistan 3
RO - Romania 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MU - Mauritius 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BO - Bolivia 1
ET - Etiopia 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LY - Libia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
NA - Namibia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
UG - Uganda 1
Totale 10.064
Città #
Fairfield 755
Ashburn 479
Singapore 432
Woodbridge 391
Jacksonville 316
Houston 311
Seattle 290
Hong Kong 280
Cambridge 257
Wilmington 248
Beijing 211
Chandler 202
Ann Arbor 179
San Jose 167
The Dalles 150
Princeton 146
New York 117
Nanjing 102
Helsinki 84
Los Angeles 80
Dublin 79
Istanbul 70
Dearborn 64
Lauterbourg 64
Warsaw 64
Ho Chi Minh City 59
Munich 55
Des Moines 42
Dallas 41
Changsha 36
Chicago 36
Nanchang 36
Hanoi 34
São Paulo 34
Moscow 33
Council Bluffs 30
San Diego 30
Hebei 29
San Francisco 29
Shanghai 29
Brescia 28
Redondo Beach 27
Buffalo 26
Shenyang 25
London 24
Orem 24
Brno 22
Boardman 20
Brussels 19
Jinan 19
Santa Clara 19
Turku 19
San Mateo 18
Atlanta 17
Denver 17
Montreal 17
Tianjin 16
Toronto 16
Milan 15
Tokyo 15
Brooklyn 14
Olomouc 14
Zhengzhou 13
Boston 12
Jiaxing 12
Nürnberg 12
Rio de Janeiro 12
Kunming 11
Poplar 11
Stockholm 11
Belo Horizonte 10
Dhaka 10
Dong Ket 10
Rome 10
Guangzhou 9
Hangzhou 9
Amsterdam 8
Falls Church 8
Frankfurt am Main 8
Lanzhou 8
Mumbai 8
Ningbo 8
Nuremberg 8
Phoenix 8
Taizhou 8
Washington 8
Augusta 7
Chennai 7
Da Nang 7
Genoa 7
Jeddah 7
Manchester 7
Mexico City 7
Baghdad 6
Betim 6
Biên Hòa 6
Campinas 6
Charlotte 6
Haiphong 6
Kilburn 6
Totale 6.845
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 248
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 228
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 209
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 209
Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study 207
Acute functional reactivation of the language network during awake intraoperative brain mapping 204
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 201
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 195
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 193
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 192
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 190
Palbociclib inhibits proliferation of human adrenocortical tumor cells 189
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 189
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 187
Regression of advanced neuroendocrine tumors among patients receiving placebo 187
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 183
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 177
Detection of serum proteomic profile predictive for epidermal growth factor receptor tyrosine kinase inihibitors (EGFR-TKIs) in 1st line chemotherapy responders 174
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 173
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 173
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 171
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 168
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 168
Serum vitamin D and prostate cancer prognosis: The story continues 167
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 167
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations 166
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 165
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 163
Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer 160
Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma 157
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 155
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 153
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 153
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension 151
Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies 150
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: Prediction of the response to the first-line chemotherapy 148
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 147
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 147
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions 146
Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions 143
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study 142
Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology 138
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 136
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 129
CT scanner for the pleural staging of pleural cancer: How accurate is this? 125
Malignant pleural mesothelioma: from the bench to the bedside 119
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It? 118
Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study 117
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough 115
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 114
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions 111
False Negative Pleural Cytology in Patient with Malignant Pleurisies: Is Pleural EpCAM-Positive Microparticles a Complementary Tool for Diagnosis? 111
CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer 111
Onde elettromagnetiche ad alta frequenza e bassa intensit. nel trattamento delle ulcere cutanee: 8 casi clinici. 107
Malignant pleural mesothelioma signs and symptoms 105
ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort 104
THE ASSOCIATION BETWEEN PROTEOMIC PROFILE DETECTED BEFORE 2ND/3RD LINE EGFR-TKIS AND RESPONSE TO 1ST LINE CHEMOTHERAPY 95
Pathologie pleurale 91
IMPACT OF CLINICAL PARAMETERS ON OUTCOME OF PATIENTS TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER 87
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis 78
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 75
EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice 74
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation 70
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis 69
Onde elettromagnetiche ad alta frequenza e bassa intensità nel trattamento delle ulcere cutanee: 8 casi clinici 68
Thoracic Cytological Specimens Obtained In Routine Clinical Practice And EGFR, Kras, Her2, Braf And Pi3kca Mutation Status In Metastatic Cancer Patients 68
Maintenance with Lanreotide in SCLC Patients, Expressing Somatostatine Receptors, after Response to First Line Therapy 66
Tissue factor positive microparticles remain undetectable by flow cytometry in pleural fluids from cancer patients despite high level of procoagulant activity 66
Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspiration 65
Multigene Mutation Analysis Of Mediastinal Lymph Nodes Assessed By Endobronchial Ultrasound-Guided Needle Aspiration: A Prospective Study 64
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial 64
PROTEOMIC SIGNATURE TO IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH EGFR-TKIS 63
Is DNA repair a potential target for effective therapies against malignant mesothelioma? 55
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 48
Totale 10.221
Categoria #
all - tutte 47.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 0 0 0 0 0 68
2021/2022592 38 66 33 45 9 36 21 63 25 72 47 137
2022/2023589 85 24 16 44 53 130 3 74 105 1 24 30
2023/2024618 47 22 63 34 33 91 19 21 154 9 6 119
2024/20251.323 20 5 8 199 145 93 117 53 183 74 259 167
2025/20262.739 262 440 240 426 321 175 331 77 150 204 96 17
Totale 10.221